Douglas Richard
- SEC CIK
- 0001021015
In the past year, 1 open-market purchase filing worth $98.0K and no sales.
Current role at each company
- NVAX Novavax IncDirectoras of Jun 23, 2026
- MXCT Maxcyte, Inc.Directoras of Jun 22, 2026
- ALDX Aldeyra Therapeutics, Inc.Directoras of Jun 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $98.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$98.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Douglas Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALDX Aldeyra Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 (view filing) | Mar 19 | 1 day | Douglas RichardDirector | PPurchase | +70.0K | $1.40 | +$98.0K | +56.0%195.0K after |
MXCT Maxcyte, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 (view filing) | Aug 13 | Same day | Douglas RichardDirector | PPurchase | +80.0K | $1.39 | +$111.2K | +53.1%230.6K after | |
| Mar 30, 2023 (view filing) | Mar 29 | 1 day | Douglas RichardDirector | PPurchase | +80.0K | $4.32 | +$345.6K | +400.0%100.0K after | |
| Nov 23, 2021 (view filing) | Nov 22 | 1 day | Douglas RichardDirector | PPurchase | +20.0K | $11.12 | +$222.4K | New position20.0K after |